Pharmacokinetic based dosage change
12/SC/0363
Approved small_molecule completed
Quick answer
Pharmacokinetic based dosage change for Severe Haemophilia A is a Approved program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Severe Haemophilia A
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed